Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. Gilead Sciences took extraordinary steps to get ready for the moment. By Robert Langreth

The $10 Billion Startup Training AI to Replace the White-Collar Workforce
29:54

‘God, It’s Terrifying’: How the Pentagon Got Hooked on AI War Machines
21:14

How a Die-Hard Libertarian Is Negotiating Lower Health-Care Costs
22:36